Construction of recombinant adenoviral vector carrying human tissue inhibitor of metalloproteinase-1 gene and its expression in vitro

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 259-264

  Xia, Dong ^a   Yan, Lu Nan ^a   Tong, Yu ^b   Wang, Xin Ping ^a   Zhang, Ming Man ^a   Zhao, Lan Ying ^b  

^a SICHUAN UNIVERSITY   (China)

^b Chengdu Di'Ao Pharmaceutical Company   (China)

Author keywords

Gene therapy; Hepatocellular carcinoma; Recombinant adenoviral vector; Tissue inhibitor of metalloproteinase

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CELL STRAIN HEK293; CELL TRANSFORMATION; CONTROLLED STUDY; DNA PACKAGING; DNA SEQUENCE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSCRIPTION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PLASMID; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHUTTLE VECTOR; VIRUS RECOMBINANT; VIRUS TITRATION; WESTERN BLOTTING;

ADENOVIRIDAE; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 20344395350     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Joo YE, Seo YH, Lee WS, Kim HS, Choi SK, Rew JS, et al. Expression of tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma. Korean J Intern Med 2000;15:171-178.
2. Yang BH, Xia JL, Huang LW, Tang ZY, Chen MS, Li JQ, et al. Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int 2004; 3:194-198.
3. Yoshiji H, Kuriyama S, Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 2002;23:348-356.
4. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res 2003;63:8312-8317.
5. Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, Cao J, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001;158:1921-1928.
6. Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19:6642-6650.
7. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:163-176.
8. Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibit tumor growth and invasion. Oncogene 2002;21:8011-8019.
9. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-792.
10. Brew K, Dinakarpandian D, Nagase H. Tissue inbibitors of metalloproteinase: evolution, structure and function. Biochim Biophys Acta 2000;1447:267-283.
11. Fassina G, Ferrari N, Brigati C, Optreia M, Naferte H, Euilia L, et al. Tissue inhibitors of metalloproteinase: regulation and biological activities. Clin Exp Metastasis 2000;18:111-120.
12. Jiang YF, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinase in cancer. Oncogene 2002;21: 2245-2252.
13. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokho R. Timp-1 is important for epithelial proferation and branching morphogenesis during mouse mammary development. Develop Biol 1999;211:238-254.
14. Murphy G, Knauper V, Lee MH, Amour A, Worley JR, Hutton M, et al. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp 2003;70:65-80
15. Kim JR, Kim CH. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells. Int J Biochem Cell Biol 2004;36:2293-2306.
16. Matsumoto E, Nakatsukasa H, Nouso K, Kobayashi Y, Nakamura S, Suzuki M, et al. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma, Liver Int 2004;24:379-383.
17. He TC, Zhou SB, Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-2514.
18. Xia D, Zhang MM, Yan LN. Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int 2004; 3:332-336.
19. Zhou XD. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int 2002;1:35-41.
20. Mckenna GJ, Chen Y, Smith RM, Meneghetti A, Ong C, McMaster R, et al. A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg 2002;183:588-594.
21. Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmouliere A, Rosenbaum J. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 2002;97:157-162.
22. Giannelli G, Bergamini C, Fransvea E, Marinosci F, Quaranta V, Antonaci S. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest 2001;81:613-627.
23. Chung TW, Moon SK, Lee YC, Kim JG, Ko JH, Kim CH. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch Biochem Biophys 2002; 408:147-154.
24. Gianluigi G, Carlo B, Felice M, Emilia F, Michele Q, Luigi L, et al. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 2002;97:425-431.
25. Li H, Lindenmeyer F, Grenet C, Opolon P, Menashi S, Soria C, et al. AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther 2001;12:515-526.
26. Rouis M, Adamy C, Duverger N, Lesnik P, Horellou P, Moreau M, et al. Adenovirus-mediated overexpression of tissue inhibitors of metalloproteinase-1 reduces atherosclerotic lesions in Apolipoprotein E-deficient mice. Circulation 1999;100:533-540.
27. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitors of metalloproteinase-1 -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. J Clin Invest 1998; 101: 1478-1487.
28. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knauper V, et al. The in vivo activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 2000;473:275-279.
29. Tran PL, Vigneron JP, Pericat D, Dubois S, Cazals D, Hervy M, et al. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3. Cancer Gene Ther 2003;10:435-444.
30. Jiang YF, Wang MS, Celoker MY, Liu YE, Xiang Q, Goldberg ID, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitors of matrix metalloproteinases 4 gene delivery. Cancer Res 2001;61:2365-2370.
31. Mohammed AM, Valerie AS, David LE, Andrew HB, Andrew CN. Adenovirus mediated gene delivery of tissue inhibitors of metalloproteinases-3 induces death in retinal pibment epithelial cells. Br J Ophthalmol 2002;86:97-101.
32. Brand K, Baker AH, Alejandra PC, Possling A, Sachajat M, Geheeb M, et al. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitors of metalloproteinases-2 into the liver tissue. Cancer Res 2000;60:5723-5730.
33. Rigg AS, Lemoine NR. Adenoviral delivery of TIMP-1 or TIMP-2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vitro. Cancer Gene Ther 2001;8:869-878.
34. Bloomston M, Shafii A, Zervos EE, Rosemurgy AS. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res 2002;102:39-44.
35. Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Bahou WF, Zucker S. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem 2004;279:14129-14139.